You are here: Home » International » News
Business Standard

Nepal to administer China's coronavirus vaccines to citizens from April 7

Nepal will start its second phase of the Covid-19 inoculation drive from April 7 using a China-donated vaccine to fight against the deadly infection

Nepal | Coronavirus Vaccine | Coronavirus

Press Trust of India  |  Kathmandu 

Representative Image
Representative Image

will start its second phase of the COVID-19 inoculation drive from April 7 using a China-donated vaccine to fight against the deadly infection, according to the health ministry.

The first phase of the vaccination drive began in January with the one million doses of Oxford-vaccine provided by India under grant assistance in sync with its 'Neighbourhood First' policy.

The second phase will begin from Wednesday, April 7. The 800,000 doses of the China manufactured vaccine - Vero Cell- against COVID-19 infection will be administered to the frontline workers as well as those involved in trans-Himalayan trade activities in the mountainous region, Dr Jageshwor Gautam, the spokesperson for the Ministry of Health and Population, said.

Nepali students studying in China under scholarship schemes and those preparing to visit China for further studies will also receive the Chinese vaccine, Gautam said.

As many as 500,000 of the total 900,000 people targeted for vaccination have already received COVID-19 vaccines. These 800,000 doses of China-donated vaccines will be administered to the remaining 400,000 people of the targeted group, he added.

Chinese ambassador to Nepal, Hou Yanqi, had handed over COVID-19 vaccines to the Minister for Health and Population Hridayesh Tripathi amidst a special function organised in Kathmandu on March 29.

had granted a conditional emergency approval for use of Vero Cell, the vaccine manufactured by China's Beijing Institute of Biological Products earlier on February 18.

Nepal, home to 28 million people, has recorded 277,944 infections and 3032 deaths, according to a tally by Johns Hopkins University.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, April 05 2021. 10:38 IST